ÌìÃÀÓ°Ôº

CareersÌìÃÀÓ°ÔºPressCorporate
Login
  1. Home
  2. Clinical Fields
  3. Organ Transplantation - ISDs
  4. Mycophenolic Acid Assays
  5. EMIT 2000 MPA

EMIT 2000 Mycophenolic Acid Assay*

MPA concentrations are highly variable in patients receiving the drug. As such, treatment needs to be individualized depending on transplant type, co-administrated drugs, time post transplant, and other factors. The EMIT® 2000 MPA assay is a simple, easy-to-use solution to help clinicians better manage MPA therapy in transplant patients.

Features

  • Results available within 10 minutes
  • Utilizes plasma samples - no pretreatment required
  • Assay can be performed alongside 3 other immunosuppressive drugs
  • Correlates to the HPLC reference method

ÌýAdvantages

  • Streamlined ISD monitoring for enhanced productivity
  • Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system

Assay Specifications

Ìý

EMIT 2000 MPA Assay

Product Code

6R919UL

Sample Type

EDTA or Heparinized plasma

Pretreatment

None

Reportable Range

0.1 μg/mL–15 μg/mL

Calibration

With new reagent lot

Reagent Stability

Opened - until expiration date

Enduring Expertise for Your Immunosuppressant Drug Testing Needs

With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.

*Not available for sale in the U.S.

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.